News
42m
The Brighterside of News on MSNAntimalarial drug could treat cystic fibrosis, Duchenne muscular dystrophy, as well as some cancersIn many genetic diseases, a small error in the DNA code can have devastating effects. These errors, called nonsense mutations ...
Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for ...
"I'm honored to join the Board of Entrada as it advances its clinical-stage portfolio of Duchenne therapies and its growing ...
Dr. Tejal Aslesh Tailor is an accomplished neuroscientist and molecular biologist with years of expertise in preclinical ...
The global sales of rare neurological disease treatment is estimated to be worth USD 19.95 billion in 2025 and anticipated to reach a value of USD 40.67 billion by 2035. Sales are projected to rise at ...
Pepgen will stop development of its Duchenne MD exon-skipping therapy PGN-ED051 after increases in dystrophin levels proved ...
Two Kilkenny men are doing their bit for charity, taking on a gruelling cycle from Dublin to Istanbul, a journey which will ...
The Booster offers life sciences PhD students coaching in scientific communication. Discover, in video, the thesis topics of this year's two candidates from the Department of cell physiology and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results